BWS Financial Has Bullish Estimate for TriMas Q1 Earnings

TriMas Co. (NASDAQ:TRS) – Stock analysts at BWS Financial lifted their Q1 2025 EPS estimates for TriMas in a note issued to investors on Thursday, January 23rd. BWS Financial analyst H. Khorsand now forecasts that the industrial products company will earn $0.44 per share for the quarter, up from their prior estimate of $0.43. BWS Financial has a “Buy” rating and a $40.00 price objective on the stock. The consensus estimate for TriMas’ current full-year earnings is $1.69 per share. BWS Financial also issued estimates for TriMas’ Q2 2025 earnings at $0.54 EPS, Q3 2025 earnings at $0.61 EPS, Q4 2025 earnings at $0.46 EPS and FY2025 earnings at $2.04 EPS.

Separately, StockNews.com raised shares of TriMas from a “sell” rating to a “hold” rating in a report on Wednesday, November 13th.

TriMas Stock Down 1.1 %

TRS stock opened at $25.12 on Monday. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. TriMas has a 1-year low of $22.24 and a 1-year high of $28.51. The stock has a market capitalization of $1.02 billion, a P/E ratio of 39.25 and a beta of 0.67. The business has a fifty day moving average price of $25.07 and a 200-day moving average price of $25.45.

TriMas (NASDAQ:TRS) last posted its quarterly earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.57 by ($0.14). TriMas had a return on equity of 9.21% and a net margin of 2.93%. The company had revenue of $229.36 million during the quarter, compared to analysts’ expectations of $239.33 million. During the same period in the prior year, the firm earned $0.57 EPS. TriMas’s revenue for the quarter was down 2.5% compared to the same quarter last year.

Hedge Funds Weigh In On TriMas

A number of institutional investors have recently bought and sold shares of the stock. Impax Asset Management Group plc lifted its position in shares of TriMas by 216.4% during the 3rd quarter. Impax Asset Management Group plc now owns 410,000 shares of the industrial products company’s stock valued at $10,467,000 after buying an additional 280,431 shares in the last quarter. Wellington Management Group LLP raised its position in shares of TriMas by 10.7% during the 3rd quarter. Wellington Management Group LLP now owns 2,619,359 shares of the industrial products company’s stock valued at $66,872,000 after purchasing an additional 252,537 shares during the period. Invenomic Capital Management LP purchased a new position in shares of TriMas during the 3rd quarter valued at $3,655,000. Western Standard LLC boosted its holdings in TriMas by 86.6% in the 3rd quarter. Western Standard LLC now owns 169,069 shares of the industrial products company’s stock worth $4,316,000 after buying an additional 78,450 shares during the period. Finally, Atom Investors LP increased its stake in TriMas by 62.0% in the 3rd quarter. Atom Investors LP now owns 179,328 shares of the industrial products company’s stock worth $4,578,000 after buying an additional 68,608 shares in the last quarter. 99.42% of the stock is owned by institutional investors.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.